SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotechnology Value Fund, L.P.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (212)7/24/1998 3:27:00 PM
From: scaram(o)ucheRead Replies (1) of 4974
 
>> At the same time, the underwriting business is changing. The houses that traditionally
underwrite biotech have been picked off (e.g., Robertson Stephens) or are on the
blocks (e.g., H&Q). They will increasing(ly) compete for big deals and ignore the
companies that need $15-40 million. <<

Please note that Freudenthal (referenced in previous post) is from BA Robertson Stephens.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News